324 filings
Page 3 of 17
8-K
h32m3j04 nwn
7 Jun 22
Departure of Directors or Certain Officers
4:45pm
8-K
xaq4nzs w57onqnc
31 May 22
Andrew Jackson Appointed Chief Financial Officer
7:30am
8-K
81wnicv5
27 May 22
Brooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-Q
4:35pm
8-K
q7u gmh35sijw0enf
19 Apr 22
Changes in Registrant's Certifying Accountant
4:30pm
8-K
itdhj7y xtq4htaz
15 Apr 22
Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results
5:18pm
8-K
yy86b76o qome05
9 Mar 22
Brooklyn ImmunoTherapeutics Announces Closing of $12 Million Private Placement
4:21pm
8-K
iziaudmdzbhoefcmj
24 Jan 22
Changes in Registrant's Certifying Accountant
5:00pm
8-K
qoysz9xt j58
20 Jan 22
Departure of Directors or Certain Officers
7:40am
8-K
v30ee
5 Jan 22
Cost Associated with Exit or Disposal Activities
6:06am
8-K
75echt7w5g
21 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
4qx73fs5
23 Nov 21
Other Events
8:00am
8-K
py9 co7etd5u
12 Nov 21
Regulation FD Disclosure
6:05am
8-K
2rid whg7sh
14 Oct 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K/A
zzszcn4eww gsfe0jkv
1 Oct 21
Financial Statements and Exhibits
4:31pm
8-K
otf8pupo34ep3wt
23 Sep 21
Changes in Registrant's Certifying Accountant
4:30pm
8-K
gahcvf 3nc6
20 Sep 21
Regulation FD Disclosure
4:29pm
8-K
2ceomhzh1j
14 Sep 21
Other Events
7:00am
8-K
sbpbphtb42 31
13 Sep 21
Submission of Matters to a Vote of Security Holders
6:05am
8-K
eluiwggomjjseg2kbm
9 Sep 21
Regulation FD Disclosure
6:05am
8-K
iz9 4u694hgfj7rynv8
20 Aug 21
Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum
4:45pm